Showing 1 to 2 of 2 results


Survey Reveals Growing Desire for Early Alzheimer's Detection
A national Alzheimer's Association survey of 1,700 Americans aged 45+ reveals 79% want early Alzheimer's detection via blood tests, reflecting a shift in attitudes towards proactive healthcare and informed decision-making due to new diagnostic and treatment options.
Survey Reveals Growing Desire for Early Alzheimer's Detection
A national Alzheimer's Association survey of 1,700 Americans aged 45+ reveals 79% want early Alzheimer's detection via blood tests, reflecting a shift in attitudes towards proactive healthcare and informed decision-making due to new diagnostic and treatment options.
Progress
32% Bias Score

NHS to Decide on Alzheimer's Drug HMTM by April
The UK's National Health Service (NHS) is evaluating hydromethylthionine mesylate (HMTM), an oral drug, for treating Alzheimer's disease; early trials show promise in slowing disease progression, with a decision expected by April.

NHS to Decide on Alzheimer's Drug HMTM by April
The UK's National Health Service (NHS) is evaluating hydromethylthionine mesylate (HMTM), an oral drug, for treating Alzheimer's disease; early trials show promise in slowing disease progression, with a decision expected by April.
Progress
44% Bias Score
Showing 1 to 2 of 2 results